Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug labels
Pharma
Regulatory tracker: J&J's Tremfya picks up 2 pediatric FDA nods
Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Fraiser Kansteiner
,
Zoey Becker
,
Angus Liu
,
Kevin Dunleavy
,
Eric Sagonowsky
Sep 29, 2025 2:30pm
Amarin, after stock crash and layoffs, revives patent lawsuit
Jun 26, 2024 1:01pm
GSK's Arexvy has expanded its label into adults ages 50-59
Jun 7, 2024 6:45pm
Analysts tip label expansion to bolster GSK's hand in RSV fight
Feb 7, 2024 7:20am
Drug mix-up prompts Azurity to recall 1 lot of Zenzedi
Jan 26, 2024 9:41am
Teva hits wall in attempt to overturn 'skinny label' loss to GSK
May 15, 2023 11:15am